AbbVie’s Aquipta & GSK’s Jesduvroq Move Closer To EU Market

 
• By Neena Brizmohun

AbbVie’s migraine prophylactic and GSK’s treatment for anemia associated with chronic kidney disease were both recommended for pan-EU marketing approval by the European Medicines Agency this week.

Close-up of European Names on Maps
Two new drugs are set to be approved for use in Europe soon • Source: Shutterstock

More from Europe

More from Geography